News

Investors Can Lead Class Action Against ZoomInfo Technologies

Investors Can Lead Class Action Against ZoomInfo Technologies

Examining the Class Action Against ZoomInfo Technologies

Investors in ZoomInfo Technologies, Inc. (NASDAQ: ZI) are at a pivotal moment as serious allegations emerge regarding the company's financial practices. This situation is particularly critical for those who hold shares of the company's Class A common stock. The law firm Robbins Geller Rudman & Dowd LLP has stepped in to spearhead a class action lawsuit on behalf of investors who acquired shares between November 10, 2020, and August 5, 2024. As we explore the implications of this lawsuit, it’s vital to grasp what this means for potential plaintiffs.

Understanding the Allegations

Details of the Class Period and Lawsuit

The lawsuit, titled City of Pontiac Police and Fire Retirement System v. ZoomInfo Technologies, Inc., No. 24-cv-05739 (W.D. Wash.), claims that during the established Class Period, the defendants allegedly misrepresented and failed to disclose crucial information about the company’s operational performance.

Primary Allegations Against ZoomInfo

At the heart of the allegations is the assertion that ZoomInfo's financial performance during the Class Period was artificially inflated due to the unforeseen effects of the COVID-19 pandemic. This purported increase in demand for their digital database has raised significant concerns among shareholders.

Additionally, claims have surfaced regarding questionable strategies, including coercive auto-renewal practices that pressured clients into extending contracts against their will. Such tactics are said to have harmed client relationships and artificially boosted customer retention metrics, obscuring the true state of the company’s customer interactions.

Financial Consequences for ZoomInfo

Recent Quarterly Performance

ZoomInfo's challenges became evident when, on November 1, 2022, they reported disappointing quarterly results, which were marked by heightened scrutiny from customers during contract renewals. This news resulted in a significant drop in their stock value.

Further negative developments followed on November 16, 2022, indicating that the scrutiny was ongoing and could affect revenue growth for the upcoming fiscal year. Along with stock price fluctuations, these issues raised serious concerns about the company’s overall stability moving forward.

Adjustments to Profit Guidance

The financial situation for ZoomInfo continued to evolve. On July 31, 2023, the company announced a decline in high-value customer contracts and drastically revised its revenue projections downward. This led to a sharp decline in stock prices over the following trading days, highlighting investor anxiety regarding the company's future.

Eight months later, on May 7, 2024, further revelations about poor performance metrics were compounded by a notable drop in the customer base and another cut to revenue guidance, establishing a troubling trend for investors. The outlook appears increasingly uncertain, leaving many investors questioning the stability of their financial portfolios.

The Role of the Lead Plaintiff

As events unfold, those affected by ZoomInfo’s fluctuating stock values have the opportunity to step forward as lead plaintiffs in this class action. The Private Securities Litigation Reform Act of 1995 allows any investor who has experienced tangible losses during the Class Period to apply for this role.

The lead plaintiff plays a vital role in representing fellow class members, steering the lawsuit toward justice and accountability for the impact of the allegations.

About Robbins Geller Rudman & Dowd LLP

Robbins Geller is a leading law firm known for its representation of investors in securities fraud cases. With a strong history of securing substantial recoveries for investors, the firm ranks highly in obtaining financial relief. Their team consists of 200 legal professionals dedicated to advocating for investor rights.

The firm is committed to ensuring that investor voices are heard and that appropriate actions are taken against those who violate their rights.

Frequently Asked Questions

What triggered the class action lawsuit against ZoomInfo?

The lawsuit was initiated due to allegations that ZoomInfo misrepresented its financial health and engaged in coercive practices that misled investors.

What time period does the class action cover?

The class action lawsuit covers investors who purchased ZoomInfo Class A common stock from November 10, 2020, to August 5, 2024.

How can I participate in the class action?

Investors looking to be lead plaintiffs must file their information with the court by the deadline of November 4, 2024.

What are the potential outcomes of this lawsuit?

The lawsuit may lead to monetary compensation for affected investors if the plaintiffs succeed in proving their case.

Who can serve as a lead plaintiff?

Any investor who suffered substantial financial losses in ZoomInfo can apply to serve as a lead plaintiff, representing the interests of the entire affected class.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Data Center Transformers on the Brink of a Boom

Updated Category News Views 272

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 50

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
Essity's SEK 850m Bet: Expanding Lilla Edet Facility

Updated Category News Views 99

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 183

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 24

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 84

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
SciGround Launches: A Game-Changer in Research Verification

Updated Category News Views 148

Unshackling Research Verification from the Model Folks, here's the big one—Licklider, Inc. from Tokyo lobbed a curveball with their new player in town: SciGround. This platform takes the reins on mathematically verifying AI-driven research, which is something you'll want to keep an eye on if you're at all interested in AI or research replication. Why SciGround Gets My...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 99

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 90

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading

Top 5 Most Recently Viewed Articles

AI’s Dual Nature: Growth Potential or Path to Collapse?

Updated Category News Views 242

The Dichotomy of AI: Catalyst for Growth or Collapse? Yes, AI is a catalyst, though what it catalyzes remains uncertain. The prevailing narrative suggests that our foremost challenge is the need for affordable energy to support the burgeoning data centers of AI technology. Fortunately, solutions are emerging, including the construction of modular nuclear power plants and...

Continue Reading
Ponche Kuba Refreshes Its Look While Keeping Original Flavor

Updated Category News Views 280

Exciting New Look for Ponche Kuba Today marks an exciting chapter in the world of liqueurs as Ponche Kuba unveils its new packaging design, an evolution of its iconic Caribbean rum cream liqueur. Since its inception in 1942 by Don Jaime A. J. Sprock, Ponche Kuba has maintained a loyal following due to its unique flavor and quality. Although the aesthetic has transformed,...

Continue Reading
Unlocking Crypto Success: Double Bonuses and 100x Leverage

Updated Category News Views 129

BexBack Introduces Exciting Crypto Trading Offers BexBack is revolutionizing the cryptocurrency trading landscape with dynamic offers designed for traders looking to capitalize on recent market volatility. Following significant developments in the industry, BexBack has stepped up to provide traders with exceptional options, making it easier than ever to start trading....

Continue Reading
Innovative Partnership Between eMolecules and Optic for Drug Discovery

Updated Category News Views 75

Transforming Drug Discovery with AI Collaboration In an exciting development for the pharmaceutical industry, eMolecules, a leading chemical sourcing company, has joined forces with Optic, a digital biology firm. This collaboration aims to revolutionize the drug discovery process by leveraging the power of artificial intelligence. Together, these companies are creating a...

Continue Reading
Vivani Medical Advances Canine Health with Expanded Collaboration

Updated Category News Views 214

Collaborative Efforts to Enhance Canine Metabolic Health Vivani Medical, Inc. and Okava Pharmaceuticals, Inc. have announced an exciting expansion of their partnership, aiming to enhance the metabolic health and longevity of dogs. With a mutual vision for veterinary medicine, the collaboration focuses on the development of OKV-119, a long-acting GLP-1 therapy designated...

Continue Reading